http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">

This week's FierceLifeSci is brought to you by ExL Events.
 
No other conference provides this much detail on partnership and pipeline strategies for biotech leaders... .
FierceBiotech Drug Development Forum
 

Dear Colleague,

The biggest executive-level forum for biotech strategy and networking is back! The FierceBiotech Drug Development Forum will take place October 1–3 in Boston, and we invite you to download the brochure now.
 
 

BROCHURE IS NOW AVAILABLE
DOWNLOAD BROCHURE
Brochure Download
 

No other conference provides this much detail on partnership and pipeline strategies for biotech leaders. Based on feedback from our attendees and readers, this year’s all-new agenda offers unprecedented depth into how to secure long-term funding for biotech companies while avoiding the mishaps common to early-stage research.
 
 

PROGRAM HIGHLIGHTS

  • Over 10 hours of networking during a three-day event
  • Two in-depth tracks:
    • Strategic Deal-Making and Partnering
    • Breakthroughs in Guiding Early-Stage Research
  • Two interactive workshops:
    • Improve Strategic Partnerships in Drug Repurposing
    • Add Orphan Indications to Accelerate Development
 
 

PLUS — Over 90 speakers, including:
 
Roy Barnes

Roy Baynes, CMO, Senior Vice President, Head of Clinical Development, MERCK
 
 
Douglas Ingram

Douglas Ingram, CEO, SAREPTA THERAPEUTICS
 
 
Lawrence Bloch

Lawrence Bloch, President, INFINITY PHARMACEUTICALS
 
 
Aradhana Sarin

Aradhana Sarin, Senior Vice President, Head of Business Development and Strategy, ALEXION PHARMACEUTICALS
 
 
Julie Krop

Julie Krop, CMO, AMAG PHARMACEUTICALS
 
 
Zhen Su

Zhen Su, CMO, EMD SERONO
 
 
Stephane Bancel

Stephane Bancel, CEO, MODERNA THERAPEUTICS
 
 
Barbara Dalton

Barbara Dalton, Vice President, Venture Capital, PFIZER
 
 
Sridhar Ramaswamy

Sridhar Ramaswamy, Vice President, R&D, TESARO
 
 
Nouhad Husseini

Nouhad Husseini, Vice President, Head of Business Development, REGENERON
 
 
Salim Mujais

Salim Mujais, Senior Vice President, Global Therapeutics Head, Specialty Pharma, ASTELLAS
 
 
Jeremy Sohn

Jeremy Sohn, Vice President, Global Head of Digital Business Development and Licensing, NOVARTIS
 
 
Karen Anderson

Karen Anderson, Senior Vice President, Chief Human Resources Officer, ALNYLAM PHARMACEUTICALS
 
 
Alex Waldron

Alex Waldron, Chief Commercial Officer, PEAR THERAPEUTICS
 

Register today to save your seat for this one-of-a-kind learning and networking experience! Advance conference rates expire Friday, August 17th.

I look forward to seeing you in Boston this fall!

Sincerely,

Matt Greenbaum
Production Team Leader
ExL Events, a division of Questex, LLC
 

Rebecca Willumson
Publisher 
FierceBiotech
 
 
 

Sponsors
Sponsors
 

For information on sponsorship and exhibition opportunities, please contact Andrew Sinetar at 212-400-6237 or asinetar@exlevents.com.
 


Want to reach 150,000+ FierceBiotech subscribers with your own message?
Contact aalcover@fiercemarkets.com or call 202-824-5074.



About this email: In order to receive FierceBiotech for free, we ask that you accept an occasional email promotion from our sponsors. We carefully screen each promotion and never sell or give away your personal information. If you do not want to receive these messages, you can unsubscribe entirely from FierceBiotech.
Click here to unsubscribe.

FierceMarkets, a division of Questex, LLC
1900 L St. NW Suite 400 
Washington, DC 20036
.